Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)

• Company Description    Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California. Number of Employees: 923

• Price / Volume Information    Yesterday's Closing Price: $30.63 Daily Weekly Monthly 20 Day Moving Average: 1,654,299 shares Shares Outstanding: 60.36 (millions) Market Capitalization: $1,848.85 (millions) Beta: 2.43 52 Week High: $55.33 52 Week Low: $24.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.95% -3.74% 12 Week 6.21% 2.23% Year To Date -34.09% -42.31%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 681 GATEWAY BLVD. - SOUTH SAN FRANCISCO,CA 94080 USA ph: 800-719-0671 fax: - abitting@twistbioscience.com http://www.twistbioscience.com

• General Corporate Information    Officers Emily M. Leproust - Chief Executive Officer and Chair of the Board of Adam Laponis - Chief Financial Officer Robert F. Werner - Chief Accounting Officer Nelson C. Chan - Director Robert Chess - Director Peer Information Twist Bioscience Corporation (CORR.) Twist Bioscience Corporation (RSPI) Twist Bioscience Corporation (CGXP) Twist Bioscience Corporation (BGEN) Twist Bioscience Corporation (GTBP) Twist Bioscience Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90184D100 SIC: 2836 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/14/25 Share - Related Items Shares Outstanding: 60.36 Most Recent Split Date: (:1) Beta: 2.43 Market Capitalization: $1,848.85 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.38 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.30 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/14/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.87 Price/Cash Flow: - Price / Sales: 5.10 EPS Growth vs. Year Ago Period: 45.35% vs. Previous Quarter: 28.79% Sales Growth vs. Year Ago Period: 17.91% vs. Previous Quarter: 3.52% ROE 09/30/25 - - 06/30/25 - -29.03 03/31/25 - -33.48 ROA 09/30/25 - - 06/30/25 - -21.77 03/31/25 - -25.34 Current Ratio 09/30/25 - - 06/30/25 - 3.90 03/31/25 - 4.51 Quick Ratio 09/30/25 - - 06/30/25 - 3.60 03/31/25 - 4.24 Operating Margin 09/30/25 - - 06/30/25 - -37.00 03/31/25 - -44.77 Net Margin 09/30/25 - - 06/30/25 - -23.51 03/31/25 - -54.98 Pre-Tax Margin 09/30/25 - - 06/30/25 - -23.41 03/31/25 - -54.87 Book Value 09/30/25 - - 06/30/25 - 7.92 03/31/25 - 7.38 Inventory Turnover 09/30/25 - - 06/30/25 - 7.79 03/31/25 - 7.65 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.03 03/31/25 - 0.03 Debt-to-Capital 09/30/25 - - 06/30/25 - 3.04 03/31/25 - 3.30

Powered by Zacks Investment Research ©